Global Cardiac Pacemaker Market to Reach US$ 6.8 Billion by 2032, Bolstered by Increasing Prevalence of CVDs

April 05, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Cardiac Pacemaker Market by Type (Implantable, External), Technology (Biventricular, Single Chambered, Dual Chambered, and Others), Indication (Arrhythmias, Congestive Heart Failure, and Others), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and Region 2024-2032," the global cardiac pacemaker market size reached US$ 5.0 Billion in 2023. A cardiac pacemaker is a small, battery operated medical electronic device implanted in the chest or abdomen to regulate the heartbeat. It operates by sending electrical signals to the heart muscle, which causes it to contract and pump blood. It comprises electronic and mechanical components, including microprocessors, sensors, electrodes, wires, leads, and housing. It aids in reducing the risk of complications like stroke and heart failure that can be caused by an irregular and slow heart rate. Nowadays, a cardiac pacemaker can be customized according to the requirements of the patient.

Global Cardiac Pacemaker Market Trends:

The surging prevalence of chronic diseases, such as arrhythmias, congenital heart disease, atrial fibrillation, and cardiovascular diseases (CVDs), represents one of the key factors catalyzing the demand for cardiac pacemakers around the world. Moreover, rising cases of heart failure on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses are augmenting the growth of the market. In addition, the growing geriatric population, which is more susceptible to these medical conditions, is influencing the market positively. Apart from this, leading players are launching small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant. They are also introducing cardiac pacemakers with longer battery life and remote monitoring capabilities that enable healthcare professionals to track the performance of the device and heart function of patients remotely utilizing a smartphone. Furthermore, the increasing awareness about the available treatment alternatives for heart-related diseases is creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 6.8 Billion by 2032, exhibiting a CAGR of 3.5% during 2024-2032.

Market Summary:

On the basis of the type, the market has been bifurcated into implantable and external. Presently, implantable holds the largest market share.
Based on the technology, the market has been segmented into biventricular, single chambered, dual chambered, and others. Dual chambered currently accounts for the biggest market share.
On the basis of the indication, the market has been categorized into arrhythmias, congestive heart failure, and others. At present, arrhythmias dominates the market.
Based on the end user, the market has been segregated into hospitals and clinics, ambulatory surgery centers, and others. Hospitals and clinics currently represented the biggest market segment.
Region wise, the market has been divided into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico and others); and the Middle East and Africa. Amongst these, North America (the United States and Canada) enjoys the leading position in the market.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., and Shree Pacetronix Ltd.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Types Covered	Implantable, External
Technologies Covered	Biventricular, Single Chambered, Dual Chambered, Others
Indications Covered	Arrhythmias, Congestive Heart Failure, Others
End Users Covered	Hospitals and Clinics, Ambulatory Surgery Centers, Others
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Cardiac Pacemaker Market to Reach US$ 6.8 Billion by 2032, Bolstered by Increasing Prevalence of CVDs

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.